Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novo Nordisk A/S - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVO
New York
2834
www.novonordisk.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S
Novo Nordisk (CPSE:NOVO B) Shares In Focus After Fresh Wegovy MASH Data
- Nov 7th, 2026 2:17 am
Ginkgo Bioworks Q3 Earnings Call Highlights
- Nov 7th, 2026 1:17 am
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli Lilly
- Nov 6th, 2026 2:11 pm
Novo real-world studies link Wegovy® 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with MASH at The Liver Meeting® (AASLD) 2026
- Nov 6th, 2026 1:07 pm
Eli Lilly Picks Hims & Hers to Sell Its Obesity Drugs, Days Before Hims Reports
- Nov 6th, 2026 12:40 pm
Eli Lilly Strikes Surprising Deal With Hims & Hers
- Nov 6th, 2026 12:25 pm
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugs
- Nov 6th, 2026 10:57 am
Hims & Hers Gained as the Market Dipped. Here’s What the November 9 Report Must Prove
- Nov 6th, 2026 10:51 am
Hims & Hers Rises 4% as Eli Lilly Deal Brings Zepbound to Its Platform: “A Clear Positive”
- Nov 6th, 2026 7:39 am
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement
- Nov 6th, 2026 6:24 am
What Lexicon Pharmaceuticals (LXRX) Said on Its Q3 Earnings Call
- Nov 6th, 2026 2:14 am
Lexicon Pharmaceuticals Inc (LXRX) (Q3 2026) Earnings Call Highlights: Sonata HCM Data and ...
- Nov 5th, 2026 4:18 pm
Novo Nordisk (CPSE:NOVO B) Stock Faces Q3 Earnings Profit Squeeze
- Nov 5th, 2026 11:15 am
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
- Nov 5th, 2026 8:02 am
Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly
- Nov 5th, 2026 7:03 am
NVO Q3 Earnings Call Highlights GLP-1 Growth and Raised Outlook
- Nov 5th, 2026 7:00 am
Company News for Nov 5, 2026
- Nov 5th, 2026 6:26 am
Eli Lilly Is Up 10% in a Week. Is a $5.5 Billion Guidance Raise Really That Good?
- Nov 4th, 2026 8:23 pm
Scroll